MEDPAL AI is trading 5.26% up at Β£4.00, with no fresh company-specific announcement identified for August 21, 2026.
- Latest listed RNS was August 11, concerning UK authorisation of Eli Lillyβs once-daily GLP-1 pill.
- The stronger July trading update was released August 4; available coverage does not establish either item as the direct catalyst.
- Trading is described as live, although context says the session is closed; the reason remains unclear and should be rechecked for delayed disclosure.